Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGINTERVENTIONAL

Evaluation of the Impact of a Dietary and Nutritional Intervention on Persistent Post-concussive Symptoms

Evaluation of the Impact of a Dietary and Nutritional Intervention on the Physical, Cognitive, Behavioural and Emotional Symptoms of Patients With Persistent Post-concussive Symptoms

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

Concussions affect thousands of Canadians every year. Although the effects are usually temporary, 10-15% of adults experience persistent symptoms likely to last several weeks or even months. It is suggested that nutritional interventions should be considered in concussion management because nutrition can act on several mechanisms of brain injury. However, to date, no study has assessed the impact of dietary interventions on the recovery of people with persistent post-concussive symptoms. This randomized controlled trial aims to determine the impact of a dietary and nutritional intervention on the physical, cognitive, behavioural and emotional symptoms of patients with persistent post-concussive symptoms in New Brunswick, Canada. Patients will be randomized to one of three groups: 1) dietary treatments and nutritional supplements (experimental group A), 2) nutritional supplements (experimental group B), and 3) physiotherapy treatments (control group). Patients in group A will receive four consultations with a dietitian over eight weeks, in addition to conventional physiotherapy treatments. These patients will receive nutritional counselling and omega-3, vitamin D and creatine supplements. Patients in group B will be prescribed the same supplements as those in group A by their doctor and receive physiotherapy treatments. Finally, patients in the control group will only receive physiotherapy treatments. Patient symptoms will be measured using a questionnaire constructed from tools commonly used in practice. This questionnaire will be completed at the first physiotherapy session and 2, 4 and 8 weeks after the start of the intervention.

Who May Be Eligible (Plain English)

Who May Qualify: - 16 years or older - Must be able to understand English or French - Have persistent post-concussive symptoms lasting at least 2 weeks but no longer than 6 months Who Should NOT Join This Trial: - \<16 years old - People who are breastfeeding, pregnant or plan to become pregnant in the next 2 months - People with neurological disorders (other than concussion) or a history of moderate or severe brain injury - People in an acute phase of an inflammatory bowel disease - Any physical condition prohibiting a patient from receiving physiotherapy treatments Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * 16 years or older * Must be able to understand English or French * Have persistent post-concussive symptoms lasting at least 2 weeks but no longer than 6 months Exclusion Criteria: * \<16 years old * People who are breastfeeding, pregnant or plan to become pregnant in the next 2 months * People with neurological disorders (other than concussion) or a history of moderate or severe brain injury * People in an acute phase of an inflammatory bowel disease * Any physical condition prohibiting a patient from receiving physiotherapy treatments

Treatments Being Tested

BEHAVIORAL

Experimental: Dietetic counseling

Patients will receive dietary counselling to increase caloric and nutrient intake, stabilize glycemia, and optimize hydration.

DIETARY_SUPPLEMENT

Active Comparator: Omega-3, vitamin D3 and creatine monohydrate

Patients will be prescribed dietary supplements which will be taken daily for 8 weeks, as per the supplement protocol.

BEHAVIORAL

Other : Physiotherapy treatment

Patients will receive weekly physiotherapy treatment.

Locations (1)

Universite de Moncton
Moncton, New Brunswick, Canada